4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000227
EVP & Chief Financial Officer sold 3,000 shares at $518.27 ($1,554,810)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WAGNER CHARLES F JR · EVP & Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-11 | Sale : show line 1 in the form 10b5-1 | −3,000 | $518.27 | $1,554,810 | 44,137 | D |
| Open-market sales · 3,000 sh · avg $518.27 · $1,554,810 | ||||||
Loading xslF345X05/wk-form4_1731532506.xml…